Related Experiment Video
Updated: May 8, 2026

08:17
A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
Published on: August 15, 2019
Humanized immune system animal models and their recent applications.
Nicolas Skuli1, Rudra B Amin1, A'ishah Bakayoko2
1PIGI Lab, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Animal Models and Experimental Medicine
|May 7, 2026
Summary
Humanized immune system (HIS) animal models enable in vivo study of human biology and disease. These advanced models are crucial for research in cancer, infectious diseases, and immunotherapy, bridging basic science and clinical applications.
Area of Science:
- * Immunology
- * Preclinical Research
- * Translational Medicine
Background:
- * Humanized immune system (HIS) animal models are vital for studying human biology and diseases in vivo.
- * These models are created by engrafting human hematopoietic stem cells (HSC) into immunodeficient hosts, establishing a functional human immune system.
- * HIS models have diverse applications in cancer research, infectious diseases, regenerative medicine, and immunotherapy.
Purpose of the Study:
- * To provide a comprehensive overview of current HIS model generation techniques.
- * To evaluate the strengths and limitations of existing HIS models.
- * To discuss emerging innovations and the role of HIS models in preclinical drug development.
Main Methods:
- * Review of HSC-based approaches for HIS model generation.
- * Analysis of host strain selection criteria.
- * Examination of genetically engineered mouse models expressing human cytokines and HLA molecules.
Main Results:
- * HIS models facilitate the study of immune responses, disease mechanisms, and therapeutic interventions in a relevant physiological setting.
- * Identified limitations include incomplete immune reconstitution and species-specific incompatibilities.
- * HIS models are increasingly utilized in preclinical drug development.
Conclusions:
- * HIS models offer significant opportunities for advancing basic research and clinical translation.
- * Ongoing innovations like multitissue humanization and genome editing are enhancing HIS model capabilities.
- * Continued evolution of HIS models promises to accelerate biomedical discoveries.
